Elderly acute myeloid leukemia: patients are not all the same

被引：0

作者：

Schaich, M ^{[1
]}

机构：

[1] Univ Hosp CG Carus, Dept Med 1, D-01307 Dresden, Germany

来源：

HAEMATOLOGICA | 2004年 / 89卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：261 / 262

页数：2

共 14 条

[1] ACUTE MYELOGENOUS LEUKEMIA IN THE ELDERLY - RETROSPECTIVE STUDY OF 235 CONSECUTIVE PATIENTS [J].

BAUDARD, M ;

MARIE, JP ;

CADIOU, M ;

VIGUIE, F ;

ZITTOUN, R .

BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (01) :82-91

[2] Allogeneic stem-cell transplantation from related and unrelated donors in older patients with myeloid leukemia [J].

Bertz, H ;

Potthoff, K ;

Finke, J .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) :1480-1484

[3] How I treat older patients with AML [J].

Estey, EH .

BLOOD, 2000, 96 (05) :1670-1673

[4] SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes [J].

Giles, FJ ;

Stopeck, AT ;

Silverman, LR ;

Lancet, JE ;

Cooper, MA ;

Hannah, AK ;

Cherrington, JM ;

O'Farrell, AM ;

Yuen, HA ;

Louie, SG ;

Hong, W ;

Cortes, JE ;

Verstovsek, S ;

Albitar, M ;

O'Brien, SM ;

Kantarjian, HM ;

Karp, JE .

BLOOD, 2003, 102 (03) :795-801

[5] The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial [J].

Grimwade, D ;

Walker, H ;

Harrison, G ;

Oliver, F ;

Chatters, S ;

Harrison, CJ ;

Wheatley, K ;

Burnett, AK ;

Goldstone, AH .

BLOOD, 2001, 98 (05) :1312-1320

[6] Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial [J].

Karp, JE ;

Lancet, JE ;

Kaufmann, SH ;

End, DW ;

Wright, JJ ;

Bol, K ;

Horak, I ;

Tidwell, ML ;

Liesveld, J ;

Kottke, TJ ;

Ange, D ;

Buddharaju, L ;

Gojo, I ;

Highsmith, WE ;

Belly, RT ;

Hohl, RJ ;

Rybak, ME ;

Thibault, A ;

Rosenblatt, J .

BLOOD, 2001, 97 (11) :3361-3369

[7]

Leith CP, 1997, BLOOD, V89, P3323

[8]

LOWENBERG B, 1989, J CLIN ONCOL, V7, P1268

[9]

Pulsoni A, 2004, HAEMATOLOGICA, V89, P296

[10] Efficacy and safety of gemtuzumab ozogamicin in patients with poor-prognosis acute myeloid leukemia [J].

Roboz, GJ ;

Knovich, MA ;

Bayer, RL ;

Schuster, MW ;

Seiter, K ;

Powell, BL ;

Woodruff, RD ;

Silver, RT ;

Frankel, AE ;

Feldman, EJ .

LEUKEMIA & LYMPHOMA, 2002, 43 (10) :1951-1955

← 1 2 →